14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CFRX
Delisted

ContraFect Corporation Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.0500
+0 (+0%)
At Close: Mar 04, 2024
Forecast Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0500 $0.0500 Monday, 4th Mar 2024 CFRX stock ended at $0.0500. During the day the stock fluctuated 0% from a day low at $0.0500 to a day high of $0.0500.
90 days $0.0457 $0.0620
52 weeks $0.0430 $3.95

Historical ContraFect Corporation prices

Date Open High Low Close Volume
Jan 26, 2023 $0.0950 $0.101 $0.0910 $0.0921 20 980 835
Jan 25, 2023 $0.113 $0.120 $0.0950 $0.100 34 108 074
Jan 24, 2023 $0.0949 $0.120 $0.0906 $0.119 73 541 826
Jan 23, 2023 $0.0933 $0.0960 $0.0880 $0.0906 22 773 779
Jan 20, 2023 $0.107 $0.107 $0.0830 $0.0910 92 497 583
Jan 19, 2023 $0.0910 $0.100 $0.0860 $0.0940 17 318 800
Jan 18, 2023 $0.0990 $0.0990 $0.0890 $0.0910 5 300 200
Jan 17, 2023 $0.101 $0.104 $0.0943 $0.0954 5 225 604
Jan 13, 2023 $0.100 $0.105 $0.0954 $0.101 6 117 366
Jan 12, 2023 $0.109 $0.109 $0.0950 $0.0990 5 946 200
Jan 11, 2023 $0.102 $0.109 $0.0968 $0.106 10 651 101
Jan 10, 2023 $0.101 $0.115 $0.0996 $0.105 12 194 738
Jan 09, 2023 $0.105 $0.105 $0.0992 $0.104 1 338 013
Jan 06, 2023 $0.108 $0.108 $0.0970 $0.102 1 945 300
Jan 05, 2023 $0.105 $0.105 $0.0985 $0.104 2 209 328
Jan 04, 2023 $0.105 $0.115 $0.0977 $0.103 12 238 480
Jan 03, 2023 $0.0983 $0.104 $0.0906 $0.0990 2 949 307
Dec 30, 2022 $0.0944 $0.0973 $0.0911 $0.0960 1 023 591
Dec 29, 2022 $0.0942 $0.0982 $0.0892 $0.0922 1 640 218
Dec 28, 2022 $0.0905 $0.0945 $0.0868 $0.0900 1 374 025
Dec 27, 2022 $0.0985 $0.102 $0.0892 $0.0894 2 446 254
Dec 23, 2022 $0.102 $0.102 $0.0950 $0.0976 1 169 442
Dec 22, 2022 $0.100 $0.103 $0.0947 $0.0998 1 699 536
Dec 21, 2022 $0.104 $0.115 $0.0900 $0.103 5 471 856
Dec 20, 2022 $0.106 $0.114 $0.0959 $0.105 2 847 993
Click to get the best stock tips daily for free!

About ContraFect Corporation

ContraFect ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus bacteremia. The company also develops CF-296, an engineered lysin, used for treatment of the in... CFRX Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT